-
EHA Global Insight丨Dr. Uwe Platzbecker: Breakthrough Advances in Acute Promyelocytic Leukemia Treatment — Key Findings of the APOLLO Study
Acute promyelocytic leukemia (APL) is a highly aggressive hematological disease, and its treatment has long been a challenge in the field. Chinese scholars have contributed significantly to global APL treatment with the introduction of the arsenic trioxide (ATO) regimen. Since the publication of the APL0406 study in NEJM in 2013, the combination of all-trans retinoic…
-
Dr. Xiaoyan Ke: Sharing International Advances and Comprehensive Treatment Experience in Lymphoma/Myeloma Diagnosis and Therapy
On July 20, the 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference, along with the Gaobo Medical Academic Conference, was grandly held in Beijing. With the core concepts of “Precision, Integration, Innovation,” the conference closely followed the latest developments and frontier topics from the 29th European Hematology Association (EHA 2024) and the 2024 American…
-
Dr. Jia Fan, Dr. Jian Zhou, and Dr. Xinrong Yang’s Team: ctDNA Detection for Postoperative Minimal Residual Disease in Liver Cancer
Liver cancer is a highly prevalent and poorly prognosed malignancy, with a postoperative recurrence rate as high as 60%-70%. Postoperative minimal residual disease (MRD) is the main culprit behind cancer recurrence and metastasis, but currently, methods to detect MRD in liver cancer are very limited. At the 2024 American Society of Clinical Oncology (ASCO) Annual…
-
EHA Global Insight丨Dr. Igor Aurer: Updated Guidelines and Insights on HIV-Related Lymphoma Treatment
Patients with AIDS have a significantly higher risk of developing non-Hodgkin lymphoma (NHL) compared to the general population. To promote a deeper understanding and standardized treatment of AIDS-related lymphoma (ARL), a special session titled “ARL: EHA-ESMO Clinical Practice Guidelines” was held at the recent 29th Annual Meeting of the European Hematology Association (EHA 2024). Oncology…
-
Dr. Jihao Zhou: Unveiling the Challenges and Progress in Angioimmunoblastic T-Cell Lymphoma (AITL)
On July 20, the 5th Lymphoma & Myeloma Immunotherapy and Targeted Therapy Conference, along with the Gaobo Medical Academic Conference, was successfully held in Beijing. With the core concepts of “Precision, Integration, Innovation,” the conference closely followed the latest developments and frontier topics from the 29th European Hematology Association (EHA 2024) and the 2024 American…
-
ISTH AWARD丨Pioneer in Platelet Research Shaping the Future of Hematology: Dr. Andreas Greinacher Receives the Grant Medal
Dr. Andreas Greinacher, with over 35 years of extensive experience, has brought groundbreaking scientific discoveries to the field of hematology through his critical thinking and relentless curiosity. At the highly anticipated 2024 International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting, he was awarded the prestigious Robert P. Grant Medal, showcasing his profound expertise and…
-
ISTH Award丨Pioneer in Hematology: Dr. David Lillicrap Receives the Harold R. Roberts Award
The International Society on Thrombosis and Haemostasis (ISTH) is an inclusive organization with a global perspective, providing a valuable platform for scholars from around the world to engage, interact, and collaborate. Dr. David Lillicrap, a professor in the Department of Pathology and Molecular Medicine at Queen’s University in Canada, was honored with the Harold R.…
-
ISTH AWARD丨2024 Fundamental Research Career Development Award Winners in Hematology
The International Society on Thrombosis and Haemostasis (ISTH) announced the winners of the 2024 Fundamental Research Career Development Awards at the conference. This award aims to recognize early-career researchers who have made outstanding achievements in basic research. By acknowledging and encouraging these young scientists’ innovative ideas, ISTH hopes to support them on their path to…
Connecting Medical Expertise through Media